Anto Biosciences
YC F25San Francisco, US · Founded 2025 · 4 employees · 3 known investors
Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
Also known as Anto
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesArtificial IntelligenceGenerative AIGenomicsDrug discoveryUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (F25)
Anto Biosciences was founded in 2025 by Arvid E. Gollwitzer and David de Gruijl.
AE
Arvid E. Gollwitzerin𝕏FounderArvid E. Gollwitzer is a researcher with experience at the Broad Institute, Harvard, and MIT, and has held a lecturer position at ETH Zurich. He is the founder of Anto Biosciences.
DD
David de Gruijlin𝕏FounderDavid de Gruijl is a co-founder of Anto Biosciences with prior experience at Janssen Pharmaceuticals and research affiliations with ETH Zurich and the Gastroenterology Department at Brigham and Women's Hospital, Harvard Medical School.
Investors · 3
The YC application· Fall 2025 batch
Anto Biosciences - YC F25 - Launch Video
Arvid E. Gollwitzer
Competitors · 3
by search overlap
Octant Bio14 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Intuitive Biosciences8 shared keywordsIntuitive Bio develops immunoassays and diagnostic products and services, including non-human primate viral and TB tests and test processing, for research laboratories. The company offers assay development from proof of concept to fully-validated assays in a multiplex format supporting 1–100 markers per well.
Engage Bio7 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Companies competing with Anto Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Anto Biosciences do?
- Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
- Who founded Anto Biosciences?
- Anto Biosciences was founded by Arvid E. Gollwitzer, David de Gruijl in 2025.
- Who are Anto Biosciences's investors?
- Anto Biosciences's investors include RRE Ventures, Y Combinator, Tekedia Capital.
- Where is Anto Biosciences headquartered?
- Anto Biosciences is headquartered in San Francisco, US.